Ambu A/S
Explore this company’s associated devices, FDA decisions and regulatory history.

Ambu A/S
- Regulatory records
- 4
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 4 FDA records to the applicant name Ambu A/S. The collection includes 4 510(k) clearances. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Apr 30, 2026 to Sep 16, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code CAH appears in 1 of the 4 linked filings. The collection spans 4 FDA product codes. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: Baltorpbakken 13, Ballerup, 2750, DK. Recorded on K260309, decision dated Sep 16, 2026.
Device categories in this collection
Bronchoscope (Flexible Or Rigid); Gastroscope And Accessories, Flexible/Rigid; Electrode, Cutaneous; Filter, Bacterial, Breathing-Circuit.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Regulatory record history
Ambu aScope 5 Broncho 2.7/1.2; Ambu aScope 5 Broncho 4.2/2.2; Ambu aScope 5 Broncho 4.2/2.2 Sampler Set
K260309 · 510(k) clearanceAmbu aScope Gastro; Ambu aScope Gastro Large
K261400 · 510(k) clearanceAmbu NeurolineTM Cup MRI/CT (Models 72704/21US, 72704/23US, 72704/25US, 72704/27US) Ambu NeurolineTM Cup MRI/CT-set (Models 72704/21-1010US, 72704/21-1010US, 72704/23-1010US, 72704/25-1010US, 72704/27-1010US) Ambu NeurolineTM Cup MRI/CT-mini set (Models 72704/21-0301US, 72704/23-0301US, 72704/25-0301US, 72704/27-0301US)
K260578 · 510(k) clearanceAmbu Virobac II Exhalation Filter
K251583 · 510(k) clearance
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.